[1] Kumarathurai P,Anholm C,Nielsen OW,et al. Effects of the glucagon-like peptide-1 receptor agonist liraglutide on systolic function in patients with coronary artery disease and type 2 diabetes:a randomized double-blind placebo-controlled crossover study[J].Cardiovasc Diabetol,2016,15(1):105.
[2] Kowalczyk J,Mazurek M,Zielinska T,et al.Prognostic significance of HbA1c in patients with AMI treated invasively and newly detected glucose abnormalities[J].Eur J Prev Cardiol,2015,22(6):798-806.
[3] Yin T,Hou R,Liu S,et al.Nitrative inactivation of thioredoxin-1 increases vulnerability of diabetic hearts to ischemia/reperfusion injury[J].J Mol Cell Cardiol,2010,49(3):354-361.
[4] 杨亚冬,张文元,赵佳骏,等.骨髓间充质干细胞联合血管内皮生长因子移植治疗糖尿病兔下肢缺血的实验研究[J].医学研究杂志,2015,44(6):47-51.
[5] Povlsen JA,Lofgren B,Dalgas C,et al.Protection against myocardial ischemia-reperfusion injury at onset of type 2 diabetes in Zucker diabetic fatty rats is associated with altered glucose oxidation[J].PLoS One,2013,8(5):e64093.
[6] 何志鹏,孙维福,王松,等.糖尿病心肌缺血/再灌注损伤机制及治疗进展[J].医学综述,2013,19(5):906-909.
[7] Kitsios K,Tsapas A,Karagianni P.Glycemia and cardiovascular risk:challenging evidence based medicine[J].Hippokratia,2011,15(3):199-204.
[8] Ansley DM,Wang B.Oxidative stress and myocardial injury in the diabetic heart[J].J Pathol,2013,229(2):232-241.
[9] Tangvarasittichai S.Oxidative stress,insulin resistence,dyslipidemia and type 2 diabetes mellitus[J].World J Diabetes,2015,6(3):456-480.
[10] Zhao Q,Sun C,Xu X,et al.CD34+ cell mobilization and upregulation of myocardial cytokines in a rabbit model of myocardial ischemia[J].Int J Cardiol, 2011,152(1):18-23.
[11] Zhang O,Ji Q,Lin Y,et al.Circulating chemerin levels elevated in dilated cardiomyopathy patients with overt heart failure[J].Clin Chim Acta,2015,448:27-32.
[12] Zarrouk-Mahjoub S,Zaghdoudi M,Amira Z,et al.Pro-and anti-inflammatory cytokines in post-infarction left ventricular remodeling[J].Int J Cardiol,2016,221:632-636.
[13] 赵娅,刘飞,古远云,等.胰蛋白酶与2型糖尿病心肌病发病机制[J].重庆医科大学学报,2015,40(7):997-1000.
[14] Prabhu SD,Frangogiannis NG.The biological basis for cardiac repair after myocardial infarction:from inflammation to fibrosis[J].Circ Res,2016,119(1):91-112.
[15] Somasuntharam I,Yehl K,Carroll SL,et al.Knockdown of TNF-α by DNAzyme gold nanoparticles as an anti-inflammatory therapy for myocardial infarction[J].Biomaterials,2016,83:12-22.
[16] Liu J,Wang H,Li J.Inflammation and inflammatory cells in myocardial infarction and reperfusion injury:a double-edged sword[J].Clin Med Insights Cardiol,2016,10:79-84.
[17] 孙晓慧,牟艳玲.糖尿病心肌病血清标志物的研究进展[J].山东医药,2015,55(41):96-98. |